Position in NVAX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$49,228
-$155,980 QoQ
Shares Held
5,226
-79.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#173
of 263 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,455,922 across 465 Biotechnology names. NVAX ranks #137 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in NVAX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,228 | 5,226 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $205,208 | 25,210 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $21,348 | 3,177 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $91,867 | 10,596 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $235,209 | 37,335 | Shares | Other | 2025-08-15 | |
| 2025-03-31 | $44,543 | 6,949 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $236,295 | 29,390 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $224,283 | 17,758 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $774,715 | 61,194 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,796 | 1,631 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $66,930 | 13,944 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $49,752 | 6,872 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $237,871 | 32,015 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $117,428 | 16,945 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $305,017 | 29,671 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $581,107 | 31,929 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $1,372,923 | 26,695 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $507,595 | 6,892 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $411,755 | 2,878 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $492,775 | 2,377 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $315,492 | 1,486 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $1,071,903 | 5,912 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $801,087 | 7,184 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $226,993 | 2,095 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $961,608 | 11,537 | Shares | Other | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||